Sign in

You're signed outSign in or to get full access.

WG

W.W. GRAINGER, INC. (GWW)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 2025 delivered sales of $4.657B (+6.1% YoY) and adjusted diluted EPS of $10.21 (+3.4% YoY); reported EPS was $6.12 due to a $196M non-cash loss tied to the planned UK exit (Cromwell divestiture and Zoro UK closure) .
  • Results were modestly ahead of internal expectations on gross margin as LIFO headwinds came in lighter; adjusted operating margin was 15.2% (-40 bps YoY) with High-Touch margin pressure offset by leverage in Endless Assortment .
  • Versus S&P Global consensus, GWW posted a beat on EPS, revenue, and EBITDA for Q3 2025; management narrowed FY25 adjusted EPS to $39.00–$39.75, raised margin guidance, and trimmed the top-line range to reflect the UK exit, FX, and government shutdown impacts. Bolded below: consensus beats/misses and guidance surprises .
  • Catalysts: portfolio focus (UK exit), price actions (September/November) to offset tariffs, easing LIFO pressure into 2026, and strong Endless Assortment momentum; near-term public sector softness from the government shutdown and October hurricane lap were called out .

What Went Well and What Went Wrong

  • What Went Well

    • Endless Assortment sales +18.2% YoY (14.6% daily CC) with operating margin up to 9.8%; MonotaRO margin at 13.2% and Zoro margin at 5.8% as marketing efficiency and repeat purchase rates improved .
    • Gross margin finished ahead of prior expectations due to lower-than-expected LIFO charges; adjusted EPS rose to $10.21 (+3.4% YoY) .
    • Strong cash generation: $597M CFO and $339M FCF; $399M returned via dividends and buybacks .
    • Management quote: “We delivered results in-line with our expectations… through strong execution, industry-leading service and innovative capabilities” .
    • Management emphasis on AI: “Tech and AI will continue to be an ongoing focus… leveraging our proprietary data… to create a more seamless user experience” .
  • What Went Wrong

    • High-Touch Solutions – N.A. gross margin fell to 41.1% (-50 bps YoY) from tariff-related price/cost timing and LIFO valuation headwinds; adjusted operating margin for HTS was 17.2% (-40 bps YoY) .
    • Reported EPS down 38.0% YoY to $6.12 due to a $196M non-cash impairment tied to the UK exit; reported operating margin fell to 11.0% (-460 bps YoY) .
    • Public sector headwinds: October daily CC growth started ~1% given a prior-year hurricane lap ($30–$40M) and government shutdown; shutdown impact can be “a point or more per day” on total company sales if prolonged .

Financial Results

MetricQ3 2024Q2 2025Q3 2025
Revenue ($USD Billions)$4.388 $4.554 $4.657
Diluted EPS (Reported) ($USD)$9.87 $9.97 $6.12
Diluted EPS (Adjusted) ($USD)$9.87 $9.97 $10.21
Gross Margin (%)39.2% 38.5% 38.6%
Operating Margin (Reported, %)15.6% 14.9% 11.0%
Operating Margin (Adjusted, %)15.6% 14.9% 15.2%
Effective Tax Rate (Reported, %)24.8% 23.2% 34.7%
Effective Tax Rate (Adjusted, %)24.8% 23.2% 24.8%

Q3 2025 vs Wall Street Consensus (S&P Global)

MetricConsensus*ActualBeat/(Miss)
Primary EPS ($USD)$9.95*$10.21 +$0.26*
Revenue ($USD Billions)$4.643*$4.657 +$0.014B*
EBITDA ($USD Billions)$0.739*$0.772 +$0.033B*

Values retrieved from S&P Global.

Segment Performance

SegmentSales Growth YoYDaily CC GrowthGross MarginOperating MarginNotes
High-Touch Solutions – N.A.+3.4% +3.4% 41.1% 17.2% Tariff-related price/cost timing and LIFO headwinds; price pass actions in Sep/Nov
Endless Assortment+18.2% +14.6% n/a9.8% MonotaRO margin 13.2%; Zoro margin 5.8%; strong marketing efficiency and retention

Operating & Capital Efficiency KPIs

KPIQ3 2025
Cash from Operations ($USD Millions)$597
Capital Expenditure ($USD Millions)$258
Free Cash Flow ($USD Millions)$339
Capital Returned ($USD Millions)$399 (dividends + repurchases)
Dividend Declared$2.26 per share; payable Dec 1, 2025; record Nov 10, 2025

Non-GAAP context: Q3 2025 adjusted results exclude the non-cash loss tied to the UK exit, primarily Cromwell divestiture, recorded in SG&A; diluted adjusted EPS adds $4.09 to reported to reach $10.21 .

Guidance Changes

MetricPeriodPrevious (Aug 1, 2025)Current (Oct 31, 2025)Change
Net Sales ($B)FY 2025$17.9–$18.2 $17.8–$18.0 Lowered
Sales Growth (%)FY 20254.4%–5.9% 3.9%–4.7% Lowered
Daily Organic CC Sales Growth (%)FY 20254.5%–6.0% 4.4%–5.1% Lowered
Gross Profit Margin (%)FY 202538.6%–38.9% 38.9%–39.1% Raised
Adjusted Operating Margin (%)FY 202514.7%–15.1% 15.0%–15.2% Raised
Adjusted Diluted EPS ($)FY 2025$38.50–$40.25 $39.00–$39.75 Narrowed (midpoint unchanged)
Operating Cash Flow ($B)FY 2025$2.05–$2.25 $2.10–$2.20 Narrowed (midpoint unchanged)
CapEx (cash basis, $B)FY 2025$0.55–$0.65 $0.625–$0.675 Raised
Share Buyback ($B)FY 2025$1.05–$1.15 $1.05–$1.15 Maintained
Effective Tax Rate (%)FY 2025~23.8% ~23.8% Maintained
HTS–N.A. Adjusted Op Margin (%)FY 202516.5%–16.9% 16.9%–17.0% Raised
Endless Assortment Adjusted Op Margin (%)FY 20259.2%–9.6% 9.2%–9.5% Lowered upper bound

Management noted updated ranges reflect known tariff impacts, FX updates, and removing UK contributions; margin improvement from better price/cost and LIFO timing offsets the trimmed top-line .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 & Q2 2025)Current Period (Q3 2025)Trend
AI/Technology initiativesContinued innovation and capabilities highlighted; commitment to technology-driven customer experience Explicit focus on leveraging proprietary data with AI to enhance customer and internal productivity Building momentum
Tariffs & Price/Cost & LIFOQ2: tariff-related factors pressured gross margin; lowered FY gross margin guidance; price/cost negative LIFO headwinds persisted but were lighter than expected; price actions in Sep and Nov to align timing; expect stabilization around ~39% gross margin as inflation cools Improving alignment
Government shutdown & hurricane lapNot highlighted in Q1/Q2October daily CC growth slow (~1%) due to 2024 hurricane lap ($30–$40M) and shutdown (impact “a point or more per day”); last two weeks ~4%–5% daily CC Temporary headwinds
Portfolio focus (UK exit)No changesAgreement to divest Cromwell; proposed closure of Zoro UK; one-time non-cash after-tax loss $190–$205M (vast majority in Q3) Strategic refocus
Segment performanceQ1: EA +10.3% daily CC +15.3%; HTS daily CC +1.9% Q2: EA +19.7% (daily CC +16.3%); HTS +2.8% daily CC Q3: EA +18.2% (daily CC +14.6%); HTS +3.4%; EA margin up to 9.8%
Private label competitivenessNot highlightedSome subset faces tighter spread vs national brands under tariffs; active management of pricing strategy Mixed pressure

Management Commentary

  • Strategy and execution: “We delivered results in-line with our expectations for the quarter… through strong execution, industry-leading service and innovative capabilities” — D.G. Macpherson, CEO .
  • Margin/LIFO dynamics: “Gross margin finished ahead of… expectations on a less-than-expected LIFO impact… without this LIFO impact, our operating margin would have increased year over year” — CFO commentary .
  • Pricing actions: “Initial pricing actions back in May… September increase was much broader… On November 1… taking another [increase]… to better align price cost timing” .
  • Long-term framework: “We remain confident we can… stabilize total company gross margins around 39%… grow SG&A slower than sales… drive attractive returns” .
  • Portfolio focus: “We’ve entered into an agreement to sell our UK-based Cromwell business… focused entirely on growing our North America and Japanese businesses” .

Q&A Highlights

  • Pricing cadence: September 1 broad increase; November 1 incremental actions across contracts and non-contract business in HTS to align price/cost timing; Zoro U.S. exhibiting strong price inflation on strategic changes .
  • LIFO impact sizing/timing: Implied LIFO headwind ~70–90 bps on gross margin; expected to persist into 2026 H1, then dissipate as inflation cools and price/cost normalizes .
  • Government shutdown effect: “Every day, a point or more impact on our total business”; if prolonged, magnitude increases; hurricane lap ~$30–$40M in Oct last year .
  • UK exit financials: Q4 revenue impact ~$40M (post-close window); annualized consolidated operating margin uplift ~20 bps once UK exit completes .
  • Inventory accounting: Considered FIFO but change would require a significant cash tax payment; not switching currently .
  • Customer/verticals: Warehousing down mid-teens due to one large contract adjustment; mid-size customer growth opportunity remains, with softer prior-year comps influencing YoY rates .

Estimates Context

  • Q3 2025 actual vs consensus: EPS $10.21 vs $9.95*; revenue $4.657B vs $4.643B*; EBITDA $0.772B vs $0.739B* — all beats. Target price consensus mean $1,054.6*; consensus recommendation text not available .
  • Q4 2025 forward consensus: EPS $9.46*; revenue $4.408B*; EBITDA $0.702B*; management implied Q4 daily organic CC ~4% at midpoint, largely price-driven in HTS .
    Values retrieved from S&P Global.

Key Takeaways for Investors

  • Q3 quality: Underlying operating performance solid; adjusted margins and EPS resilient despite tariff/LIFO noise; Endless Assortment remains a growth/margin engine .
  • Consensus beats: Delivered a broad beat on EPS, revenue, and EBITDA; keep an eye on estimate revisions and margin trajectory as price actions flow and LIFO impact moderates.
    Values retrieved from S&P Global.
  • Guidance mix-shift: FY25 sales trimmed for UK exit/FX/shutdown; margins raised — a constructive signal; adjusted EPS range narrowed with unchanged midpoint .
  • Near-term headwinds: Government shutdown and hurricane lap weigh on Q4 run-rate; public sector demand may only partially catch up after resolution .
  • Pricing power: September/November actions indicate ability to pass costs; expect further pricing cycles in 2026 given supplier cost trajectories .
  • Strategic focus: UK exit simplifies portfolio to North America and Japan; should improve consolidated margins (~20 bps annual uplift on completion) and sharpen execution .
  • Medium-term thesis: As inflation cools, LIFO drag normalizes and gross margin stabilizes around ~39%; EA growth in the teens with improving drop-through supports multi-year EPS compounding .